Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunoassays exhibiting reduced cross-reactivity with hydrophobic drug analyte metabolites

Immunoassays exhibiting reduced cross-reactivity with hydrophobic drug analyte metabolites

US Patent 8288111 · Granted Oct 16, 2012

Estimated economic value: $34,067,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for measuring ubiquitin carboxy—terminal hydrolase L1 levels in blood2024
Devices and methods for sample analysis2023
Devices and methods for sample analysis2023
Methods for measuring ubiquitin carboxy-terminal hydrolase L1 levels in blood2021
Devices and methods for sample analysis2021
Composition and method for the diagnosis and treatment of iron-related disorders2017
Lysis reagent for use with capture-in-solution immunoassay2012
Alkylated interleukin-18 compositions2012
Lysis reagent for use with capture-in-solution immunoassay2011
Determination of concentration of FK778 by competitive immunoassay2007
Determination of concentration of FK778 by competitive immunoassay2007
Determination of concentration of FK778 by competitive immunoassay2007